Duminy-Luppi D, Alcaide-Aldeano A, Planas-Cerezales L, Bermudo G, Vicens-Zygmunt V, Luburich P, Del Río-Carrero B, Llatjós R, Pijuan L, Escobar I, Rivas F, Montes-Worboys A, Gutiérrez-Rodríguez Y, Rodríguez-Plaza D, Padró-Miquel A, Esteve-Garcia A, Fernández-Varas B, Flores C, Fuentes M, Dorca J, Santos S, Perona R, Günther A, Shull J, Molina-Molina M
University of Barcelona, School of Medicine. Respiratory Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Spain.
Internal Medicine Department, ICMID, Hospital Clínic de Barcelona, Barcelona, Spain.
Respir Res. 2024 Dec 18;25(1):433. doi: 10.1186/s12931-024-03063-y.
Patients with familial fibrotic interstitial lung disease (ILD) experience worse survival than patients with sporadic disease. Current guidelines do not consider family aggregation or genetic information in the diagnostic algorithm for idiopathic pulmonary fibrosis or other fibrotic ILDs. Better characterizing familial cases could help in diagnostic and treatment decision-making.
This retrospective cohort study included 222 patients with fibrotic ILD (104 familial and 118 sporadic) from Bellvitge University Hospital. Clinical, radiological, pulmonary functional tests (PFT), and histological evaluations were performed at diagnosis and follow-up. Telomere shortening and disease-associated variants (DAVs) in telomerase-related genes were analysed in familial patients and sporadic patients with telomeric clinical signs. Primary outcomes were the presence of a UIP histological pattern and disease progression.
Patients with idiopathic pulmonary fibrosis (IPF) (52%), fibrotic hypersensitivity pneumonitis (23%), and other fibrotic ILDs (25%) were included. 42% of patients underwent lung biopsy. Patients with family aggregation were younger and less frequently associated comorbidities, male sex, and smoking history. However, usual interstitial pneumonia (UIP) was more frequent on pathology (p = 0.005; OR 3.37), especially in patients with indeterminate or non-UIP radiological patterns. Despite similar PFT results at diagnosis, familial patients were more likely to present with progressive disease (p = 0.001; OR 3.75). Carrying a DAV increased the risk of fibrotic progression in familial and sporadic patients (p = 0.029, OR 5.01).
Familial patients diagnosed with different fibrotic ILDs were more likely to exhibit a histological UIP pattern and disease progression than sporadic patients, independent of radiological findings and pulmonary function at diagnosis.
Considering the diagnostic likelihood of the histological UIP pattern and disease outcome, the presence of family aggregation would be useful in the decision making of multidisciplinary committees.
与散发性疾病患者相比,家族性纤维化间质性肺疾病(ILD)患者的生存率更低。目前的指南在特发性肺纤维化或其他纤维化ILD的诊断算法中未考虑家族聚集性或遗传信息。更好地描述家族性病例有助于诊断和治疗决策。
这项回顾性队列研究纳入了贝尔维特大学医院的222例纤维化ILD患者(104例家族性和118例散发性)。在诊断和随访时进行了临床、放射学、肺功能测试(PFT)和组织学评估。对家族性患者以及有端粒临床体征的散发性患者分析了端粒缩短和端粒酶相关基因中的疾病相关变异(DAV)。主要结局是有无普通型间质性肺炎(UIP)组织学模式和疾病进展。
纳入了特发性肺纤维化(IPF)患者(52%)、纤维化性过敏性肺炎患者(23%)和其他纤维化ILD患者(25%)。42%的患者接受了肺活检。有家族聚集性的患者更年轻,合并症、男性和吸烟史的发生率更低。然而,病理上普通型间质性肺炎(UIP)更常见(p = 0.005;比值比3.37),尤其是在放射学模式不确定或非UIP的患者中。尽管诊断时PFT结果相似,但家族性患者更易出现疾病进展(p = 0.001;比值比3.75)。携带DAV增加了家族性和散发性患者纤维化进展的风险(p = 0.029,比值比5.01)。
与散发性患者相比,诊断为不同纤维化ILD的家族性患者更易出现组织学UIP模式和疾病进展,这与诊断时的放射学表现和肺功能无关。
考虑到组织学UIP模式的诊断可能性和疾病结局,家族聚集性的存在对多学科委员会的决策有用。